BRIEF published on 03/16/2026 at 07:35, 5 days 23 hours ago OSE Immunotherapeutics dévoile son calendrier financier pour 2026 Calendrier Financier Assemblée Générale Annuelle Relations Avec Les Investisseurs Industrie Biotechnologique Immunothérapies OSE
BRIEF published on 03/16/2026 at 07:35, 5 days 23 hours ago OSE Immunotherapeutics dévoile son calendrier financier pour 2026 Calendrier Financier Assemblée Générale Trésorerie OSE Immunotherapeutics Résultats Financiers 2026
BRIEF published on 03/16/2026 at 07:35, 5 days 23 hours ago OSE Immunotherapeutics unveils its financial calendar for 2026 Treasury Financial Calendar General Assembly OSE Immunotherapeutics 2026 Financial Results
BRIEF published on 03/16/2026 at 07:29, 5 days 23 hours ago UBS AG Announces Agenda for 2026 Annual General Meeting Dividend Proposal Board Elections Share Capital Reduction UBS AGM 2026 Agenda Details
BRIEF published on 03/16/2026 at 07:29, 5 days 23 hours ago UBS AG annonce l'ordre du jour de son assemblée générale annuelle de 2026 Proposition De Dividende Élections Du Conseil D'administration Réduction Du Capital Social Assemblée Générale Annuelle D'UBS 2026 Détails De L'ordre Du Jour
BRIEF published on 03/16/2026 at 07:10, 6 days ago Hypoport Reports Strong Growth in 2025 EBIT Growth Future Outlook Hypoport 2025 Financial Results Mortgage Recovery
BRIEF published on 03/16/2026 at 07:10, 6 days ago Hypoport prévoit une forte croissance en 2025 Croissance De L'EBIT Perspectives D'avenir Hypoport Résultats Financiers De 2025 Recouvrement Hypothécaire
BRIEF published on 03/16/2026 at 07:07, 6 days ago Julius Baer Group Announces Board Changes Board Of Directors Julius Baer Group Gender Diversity Olga Zoutendijk Colin Bell
BRIEF published on 03/16/2026 at 07:07, 6 days ago Le groupe Julius Baer annonce des changements au sein de son conseil d'administration Conseil D'administration Groupe Julius Baer Olga Zoutendijk Colin Bell Diversité Des Genres
BRIEF published on 03/16/2026 at 07:05, 6 days ago BioVersys Gets FDA Nod for BV100 Phase 3 Trial for Pneumonia FDA Approval Phase 3 Trial BV100 BioVersys CRAB Infections
Published on 03/20/2026 at 13:30, 1 day 17 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 18 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 8 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 10 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 10 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 10 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 11 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 12 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 12 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 13 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 13 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
